Selected article for: "accumulation rate and acute respiratory syndrome"

Author: Wen, Xu-Peng; Zhang, Yue-Zhong; Wan, Qi-Quan
Title: Non-targeted proteomics of acute respiratory distress syndrome: clinical and research applications
  • Cord-id: werg8z3g
  • Document date: 2021_3_20
  • ID: werg8z3g
    Snippet: Acute respiratory distress syndrome (ARDS) is characterized by refractory hypoxemia caused by accumulation of pulmonary fluid with a high mortality rate, but the underlying mechanism is not yet fully understood, causing absent specific therapeutic drugs to treat with ARDS. In recent years, more and more studies have applied proteomics to ARDS. Non-targeted studies of proteomics in ARDS are just beginning and have the potential to identify novel drug targets and key pathways in this disease. This
    Document: Acute respiratory distress syndrome (ARDS) is characterized by refractory hypoxemia caused by accumulation of pulmonary fluid with a high mortality rate, but the underlying mechanism is not yet fully understood, causing absent specific therapeutic drugs to treat with ARDS. In recent years, more and more studies have applied proteomics to ARDS. Non-targeted studies of proteomics in ARDS are just beginning and have the potential to identify novel drug targets and key pathways in this disease. This paper will provide a brief review of the recent advances in the application of non-targeted proteomics to ARDS.

    Search related documents:
    Co phrase search for related documents
    • absolute relative and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • abundance protein and acute ards respiratory distress syndrome: 1, 2
    • abundance protein and acute lung injury: 1, 2, 3
    • abundance protein and acute lung injury ali: 1, 2
    • abundance protein and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acid induce and acute respiratory syndrome coronavirus: 1
    • acute ards respiratory distress syndrome and liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute lung injury ali and liver injury: 1, 2, 3, 4
    • acute lung injury and liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute phase response and liver injury: 1
    • acute respiratory syndrome coronavirus and liver injury link: 1